Secondly, using the TISCH database, the cellular expression level of YRDC was relatively higher in tumor cells than in other cell types (e.g., immune cells, stromal cells, etc.)in uveal melanoma (UVM), STAD, skin cutaneous melanoma (SKCM), ovarian serous cystadenocarcinoma (OV), HNSC, and BRCA. This evidence concerns the gene YRDC and gastric adenocarcinoma.